Literature DB >> 4343784

Nephrogenic diabetes insipidus. Effects of 3,5, cyclic-adenosine monophosphate.

N F Jones, M A Barraclough, N Barnes, D G Cottom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4343784      PMCID： PMC1648252          DOI： 10.1136/adc.47.255.794

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  10 in total

1.  KINETIC ANALYSIS OF THE ANTIDIURETIC ACTION OF VASOPRESSIN AND ADENOSINE-3',5'-MONOPHOSPHATE.

Authors:  I S EDELMAN; M J PETERSEN; P F GULYASSY
Journal:  J Clin Invest       Date:  1964-11       Impact factor: 14.808

2.  The stimulation of adenosine 3,5-monophosphate production by antidiuretic factors.

Authors:  E BROWN; D L CLARKE; V ROUX; G H SHERMAN
Journal:  J Biol Chem       Date:  1963-02       Impact factor: 5.157

3.  Effect of vasopressin on renal cyclic AMP generation in potassium deficiency and patients with sickle hemoglobin.

Authors:  L G Pawlson; A Taylor; D H Mintz; J B Field; B B Davis
Journal:  Metabolism       Date:  1970-09       Impact factor: 8.694

4.  Antiduretic responses to exogenous adenosine 3',5'-monophosphate in man.

Authors:  R A Levine
Journal:  Clin Sci       Date:  1968-04       Impact factor: 6.124

5.  The effect of vasopressin and of theophylline on the concentration of adenosine 3',5'-phosphate in the urinary bladder of the toad.

Authors:  J S Handler; R W Butcher; E W Sutherland; J Orloff
Journal:  J Biol Chem       Date:  1965-11       Impact factor: 5.157

6.  Adenosinetriphosphate in rat renal papilla: effects of vasopressin and of ischemia.

Authors:  N F Jones; L G Welt
Journal:  Am J Physiol       Date:  1967-04

7.  Effect of vasopressin and cyclic AMP on permeability of isolated collecting tubules.

Authors:  J J Grantham; M B Burg
Journal:  Am J Physiol       Date:  1966-07

8.  Effects of adenosine 3',5'-monophosphate on renal function in the rabbit.

Authors:  M A Barraclough; N F Jones
Journal:  Br J Pharmacol       Date:  1970-10       Impact factor: 8.739

9.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

10.  The similarity of effects of vasopressin, adenosine-3',5'-phosphate (cyclic AMP) and theophylline on the toad bladder.

Authors:  J ORLOFF; J S HANDLER
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808
  10 in total
  2 in total

1.  Cyclic 3',5'-adenosine monophosphate (cAMP) in a 42-month-old child with clinical evidence of multiple hormonal disturbances.

Authors:  B Hager-Małecka; F Sliwa; W Janiec; W Lukas; T Piekarska
Journal:  Eur J Pediatr       Date:  1979-08       Impact factor: 3.183

2.  Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.

Authors:  W S Uttley; B Atkinson; A Adams; D Shirling
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.